Addiction Rehab Insurance Denied? How to Appeal

Substance use disorder (SUD) is a chronic, relapsing medical condition with well-established evidence-based treatments recognized by the American Society of Addiction Medicine, the American Psychiatric Association, and the Surgeon General. Residential rehabilitation programs — whether 30, 60, or 90 days — provide the structured, immersive treatment environment that many people with severe addiction need to break the cycle of substance use and prevent life-threatening outcomes. Yet insurance companies routinely deny rehab coverage, cut authorized stays short before clinical stability is achieved, or refuse to cover medically supervised detoxification. Federal parity law is your most powerful tool to challenge these decisions.

Why Insurers Deny Addiction Rehab Coverage

"Not medically necessary" using proprietary criteria. The most common denial reason. Insurers apply internal clinical criteria that are often more restrictive than the American Society of Addiction Medicine (ASAM) Criteria — the nationally recognized, evidence-based standard for determining appropriate addiction treatment level of care. Even when an addiction medicine specialist has assessed that residential treatment is clinically indicated across ASAM's six dimensions, the insurer's reviewer may override that clinical judgment using proprietary algorithms.

Concurrent review denials. Many plans approve a short initial period of residential rehab (often 5–7 days), then conduct ongoing concurrent reviews to determine whether continued stay is justified. These reviews frequently result in premature discharge while the patient remains medically and psychiatrically unstable and at high risk for relapse or overdose death.

Medical detox denials. Medically supervised detoxification is a medical necessity — not a preference — for patients withdrawing from alcohol, benzodiazepines, or opioids, where withdrawal can cause seizures, cardiovascular collapse, or death. Insurers may assert that outpatient detox is sufficient even when the clinical picture (prior withdrawal history, polysubstance use, co-occurring medical conditions) warrants inpatient medical management.

Level of care disputes. The addiction treatment continuum includes medical detox, residential treatment, partial hospitalization (PHP), intensive outpatient (IOP), and standard outpatient. Insurers routinely deny higher levels of care by asserting a lower level is adequate, ignoring the treating clinician's ASAM-based assessment of relapse risk, recovery environment, and readiness to change.

Mental Health Parity Act (MHPAEA) Explained" class="auto-link">MHPAEA parity violations. The Mental Health Parity and Addiction Equity Act prohibits insurers from applying more restrictive treatment criteria to addiction treatment than to comparable medical or surgical conditions. Using proprietary criteria that are demonstrably stricter than ASAM for addiction residential care — while approving general medical inpatient stays based on physician judgment — is a well-documented and actionable parity violation.

How to Appeal an Addiction Rehab Denial

Step 1: Obtain the ASAM Criteria Clinical Assessment

The ASAM Criteria is the nationally recognized standard for determining appropriate level of addiction treatment. Have your treating addiction medicine specialist or licensed clinician conduct and document a formal ASAM assessment across all six dimensions: acute intoxication and withdrawal potential; biomedical conditions and complications; emotional, behavioral, and cognitive conditions; readiness to change; relapse, continued use, or continued problem potential; and recovery environment. This assessment directly counters insurer criteria that are less rigorous, less comprehensive, or proprietary.

Step 2: Request the Insurer's Clinical Criteria in Writing

Under ERISA (29 U.S.C. § 1133) and ACA Section 2719, you are entitled to the specific clinical criteria your insurer used to make the denial determination. Submit this request in writing immediately. When you receive the criteria, compare them to: (a) the ASAM Criteria — the clinical gold standard — and (b) the criteria your plan applies to comparable medical or surgical inpatient stays such as cardiac hospitalization or surgical recovery. Any disparity constitutes a MHPAEA violation.

Step 3: Build the MHPAEA Parity Argument

Document specifically how your plan's addiction treatment criteria differ from its medical-surgical criteria. If the insurer approves general medical inpatient stays based on treating physician recommendation but applies a proprietary algorithmic tool with more restrictive thresholds to addiction residential care, that is a non-quantitative treatment limitation (NQTL) parity violation under 29 U.S.C. § 1185a. The 2023 MHPAEA Final Rule strengthens this requirement and obligates plans to perform and share their comparative NQTL analyses on request.

Step 4: Obtain a Comprehensive Clinical Letter

Your addiction medicine specialist, psychiatrist, or licensed clinical social worker should write a letter documenting: the specific substance use disorder diagnosis with ICD-10 code (F10.20 for alcohol use disorder, severe; F11.20 for opioid use disorder; F14.20 for cocaine use disorder; F19.20 for polysubstance use disorder; other F1x.xx codes as applicable); ASAM dimension findings across all six areas; why the requested level of care is clinically indicated; why lower levels of care are insufficient given the patient's clinical presentation, relapse risk factors, and recovery environment; and the medical and psychiatric risks of premature discharge.

Step 5: File a Formal Internal Appeal

Submit within 180 days of denial. Include the ASAM assessment, treating clinician's letter with ICD-10 codes, MHPAEA parity analysis comparing addiction treatment criteria to medical-surgical inpatient criteria, prior treatment episode documentation, and relevant medical records documenting the severity of the substance use disorder and any co-occurring medical or psychiatric conditions. Request that the appeal be reviewed by a board-certified addiction medicine specialist — not a general medical reviewer.

Step 6: File a MHPAEA Complaint and Escalate to External Independent Review: Complete Guide" class="auto-link">External Review

File a MHPAEA complaint simultaneously with your state insurance commissioner (for fully insured plans) or the U.S. Department of Labor's EBSA at dol.gov/agencies/ebsa (for ERISA plans). Include your parity analysis and the insurer's response to your request for clinical criteria. If internal appeal fails, file immediately for independent external review and request a reviewer with board certification in addiction medicine.

What to Include in Your Appeal

• Denial letter with specific stated clinical criteria and denial reason
• ASAM Criteria assessment across all six dimensions from the treating clinician
• Treating clinician's letter of medical necessity with SUD ICD-10 codes (F10.x–F19.x)
• Complete treatment history including prior treatment episodes and outcomes
• The insurer's specific denial criteria (obtained via written request)
• MHPAEA parity comparison: addiction treatment criteria versus medical-surgical inpatient criteria
• Medical records documenting SUD severity, co-occurring conditions, and withdrawal risk factors

Fight Back With ClaimBack

Insurance denials of addiction rehab are business decisions — not clinical judgments — and many violate federal parity law. With a documented ASAM assessment, a MHPAEA parity argument, and a structured appeal, you can challenge these denials and secure the coverage you are legally entitled to receive. ClaimBack generates a professional appeal letter in 3 minutes, citing MHPAEA, ASAM Criteria, and the specific federal regulations that protect your right to addiction treatment coverage. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal